95 related articles for article (PubMed ID: 23068316)
21. Camelpox: epidemiology, diagnosis and control measures.
Bhanuprakash V; Prabhu M; Venkatesan G; Balamurugan V; Hosamani M; Pathak KM; Singh RK
Expert Rev Anti Infect Ther; 2010 Oct; 8(10):1187-201. PubMed ID: 20954883
[TBL] [Abstract][Full Text] [Related]
22. Sequence analysis of C18L gene of buffalopox virus: PCR strategy for specific detection and differentiation of buffalopox from orthopoxviruses.
Singh RK; Balamurugan V; Hosamani M; Kallesh DJ; Bhanuprakash V
J Virol Methods; 2008 Dec; 154(1-2):146-53. PubMed ID: 18790707
[TBL] [Abstract][Full Text] [Related]
23. Efficacy of novel plasmid DNA encoding vaccinia antigens in improving current smallpox vaccination strategy.
Otero M; Calarota SA; Dai A; De Groot AS; Boyer JD; Weiner DB
Vaccine; 2006 May; 24(21):4461-70. PubMed ID: 16137803
[TBL] [Abstract][Full Text] [Related]
24. Microarray assay for evaluation of the genetic stability of modified vaccinia virus Ankara B5R gene.
Laassri M; Meseda CA; Williams O; Merchlinsky M; Weir JP; Chumakov K
J Med Virol; 2007 Jun; 79(6):791-802. PubMed ID: 17457926
[TBL] [Abstract][Full Text] [Related]
25. Development of a live cell culture camelpox vaccine.
Hafez SM; al-Sukayran A; dela Cruz D; Mazloum KS; al-Bokmy AM; al-Mukayel A; Amjad AM
Vaccine; 1992; 10(8):533-9. PubMed ID: 1621417
[TBL] [Abstract][Full Text] [Related]
26. Comparative sequence analysis of envelope protein genes of Indian buffalopox virus isolates.
Singh RK; Hosamani M; Balamurugan V; Satheesh CC; Rasool TJ; Yadav MP
Arch Virol; 2006 Oct; 151(10):1995-2005. PubMed ID: 16625321
[TBL] [Abstract][Full Text] [Related]
27. Detection of Vaccinia virus during an outbreak of exanthemous oral lesions in Brazilian equids.
Abrahão JS; de Souza Trindade G; Pereira-Oliveira G; de Oliveira Figueiredo P; Costa G; Moreira Franco-Luiz AP; Lopes Assis F; Bretas de Oliveira D; Mattos Paim LR; de Araújo Oliveira CE; Lemos Maia Neto A; Geessien Kroon E
Equine Vet J; 2017 Mar; 49(2):221-224. PubMed ID: 26875684
[TBL] [Abstract][Full Text] [Related]
28. Postexposure immunization with modified vaccinia virus Ankara or conventional Lister vaccine provides solid protection in a murine model of human smallpox.
Paran N; Suezer Y; Lustig S; Israely T; Schwantes A; Melamed S; Katz L; Preuss T; Hanschmann KM; Kalinke U; Erez N; Levin R; Velan B; Löwer J; Shafferman A; Sutter G
J Infect Dis; 2009 Jan; 199(1):39-48. PubMed ID: 19012492
[TBL] [Abstract][Full Text] [Related]
29. The vaccinia virus 42-kDa envelope protein is required for the envelopment and egress of extracellular virus and for virus virulence.
Engelstad M; Smith GL
Virology; 1993 Jun; 194(2):627-37. PubMed ID: 8503178
[TBL] [Abstract][Full Text] [Related]
30. Antibody neutralization of the extracellular enveloped form of vaccinia virus.
Law M; Smith GL
Virology; 2001 Feb; 280(1):132-42. PubMed ID: 11162827
[TBL] [Abstract][Full Text] [Related]
31. Antibodies against the extracellular enveloped virus B5R protein are mainly responsible for the EEV neutralizing capacity of vaccinia immune globulin.
Bell E; Shamim M; Whitbeck JC; Sfyroera G; Lambris JD; Isaacs SN
Virology; 2004 Aug; 325(2):425-31. PubMed ID: 15246280
[TBL] [Abstract][Full Text] [Related]
32. Activity of the anti-orthopoxvirus compound ST-246 against vaccinia, cowpox and camelpox viruses in cell monolayers and organotypic raft cultures.
Duraffour S; Snoeck R; de Vos R; van Den Oord JJ; Crance JM; Garin D; Hruby DE; Jordan R; De Clercq E; Andrei G
Antivir Ther; 2007; 12(8):1205-16. PubMed ID: 18240860
[TBL] [Abstract][Full Text] [Related]
33. B5r gene based sequence analysis of Indian buffalopox virus isolates in relation to other orthopoxviruses.
Singh RK; Balamurugan V; Hosamani M; DE UK; Chandra BM; Krishnappa M P G
Acta Virol; 2007; 51(1):47-50. PubMed ID: 17432943
[TBL] [Abstract][Full Text] [Related]
34. [Experiences with immunization against orthopox viruses of humans and animals using vaccine strain MVA].
Mahnel H; Mayr A
Berl Munch Tierarztl Wochenschr; 1994 Aug; 107(8):253-6. PubMed ID: 7945180
[TBL] [Abstract][Full Text] [Related]
35. Sequence analysis of haemagglutinin gene of camelpox viruses shows deletion leading to frameshift: Circulation of diverse clusters among camelpox viruses.
Venkatesan G; Kumar A; Manimuthu P; Balamurugan V; Bhanuprakash V; Singh RK
Transbound Emerg Dis; 2018 Dec; 65(6):1920-1934. PubMed ID: 30105893
[TBL] [Abstract][Full Text] [Related]
36. A PCR-based assay for detection of emerging vaccinia-like viruses isolated in Brazil.
Damaso CR; Reis SA; Jesus DM; Lima PS; Moussatché N
Diagn Microbiol Infect Dis; 2007 Jan; 57(1):39-46. PubMed ID: 16949244
[TBL] [Abstract][Full Text] [Related]
37. Increased virulence of Marek's disease virus type 1 vaccine strain CV1988 after adaptation to qt35 cells.
Majerciak V; Valkova A; Szabová D; Geerligs H; Zelník V
Acta Virol; 2001 Apr; 45(2):101-8. PubMed ID: 11719980
[TBL] [Abstract][Full Text] [Related]
38. Immunization with a single extracellular enveloped virus protein produced in bacteria provides partial protection from a lethal orthopoxvirus infection in a natural host.
Fang M; Cheng H; Dai Z; Bu Z; Sigal LJ
Virology; 2006 Feb; 345(1):231-43. PubMed ID: 16256161
[TBL] [Abstract][Full Text] [Related]
39. Extracellular enveloped vaccinia virus escapes neutralization.
Ichihashi Y
Virology; 1996 Mar; 217(2):478-85. PubMed ID: 8610439
[TBL] [Abstract][Full Text] [Related]
40. Construction of an infectious horsepox virus vaccine from chemically synthesized DNA fragments.
Noyce RS; Lederman S; Evans DH
PLoS One; 2018; 13(1):e0188453. PubMed ID: 29351298
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
